Resultados de la búsqueda 41-50 of 13280 for Carpal%2Btunnel%2Bsyndrome
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of ...
The purpose of this study is to compare disease-free survival (DFS) of patients with high-risk cutaneous squamous cell carcinoma (CSCC) treated with adjuvant ...
... 2B (Dose Expansion) with Cohort D1 (monotherapy SAR444881). A Study to ... disease is present (i.e., at diagnosis or recurrence) and not present when disease ...
The Specific Aims of this study are: 1. To identify the genetic causes of bicuspid aortic valve disease and its associated thoracic aortic disease. 2. To ...
Radioactive drugs, such as lutetium Lu 177 dotatate, may carry radiation directly to tumor cells and may reduce harm to normal cells. Lutetium Lu 177 dotatate ...
... 2 or 3 meningioma as measured by 6-month PFS rate. ... disease. Determinants of Incident Stroke ... In addition to Tier 1 procedures, at each in-person follow-up ...
... 2 or 3 meningioma as measured by 6-month PFS rate. ... disease. A Study to Evaluate MR of CSF Dynamics ... disorders. A Blood Collection Protocol to ...
Tener tres o más factores de riesgo específicos, como hipertensión arterial o grasa abdominal, aumenta el riesgo de padecer diabetes tipo 2 y enfermedad ...
The purpose of this study is to learn more about amyloid and tau burden in the brain of patients with Atypical Alzheimer's Disease and how that burden may ...
Patients in the GDC-0199+R arm will continue GDC-0199 treatment until disease progression or 2 years since treatment start, whichever comes first.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?